Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time

Liver transplantation (LT) for children with urea cycle disorders (UCDs) is capable of correcting the enzymatic defect and preventing progressive neurologic injury. We describe the characteristics and outcomes of pediatric LT recipients with UCDs. We identified all pediatric (<18 years) LT candidates with UCDs in the United Network for Organ Sharing (UNOS) database (February 2002 to September 2020). Multivariable Cox and logistic regression were used to determine risk factors for graft loss and cognitive delay, respectively. Of 424 patients, 1.9% (8/424) experienced waitlist mortality and 95.0% underwent LT (403/424). The most frequently encountered UCDs in our cohort were ornithine transcarbamylase deficiency (46.2%), citrullinemia (20.3%), and argininosuccinic aciduria (ASA; 12.9%). The 1‐, 3‐, and 5‐year graft survival rates were 90.4%, 86.3%, and 85.2%, respectively. Multivariable analysis showed a decreased risk of graft loss with increasing weight at LT (adjusted hazard ratio [aHR], 0.96; 95% confidence interval [CI], 0.94‐0.99; P = 0.02), male sex (aHR, 0.49; 95% CI, 0.28‐0.85; P = 0.01), and ASA diagnosis (aHR, 0.29; 95% CI, 0.09‐0.98; P = 0.047), when adjusting for location (intensive care/hospital/home) and graft type (both P ≥ 0.65). In multivariable logistic regression, waitlist time (adjusted odds ratio [aOR], 1.10; 95% CI, 1.02‐1.17; P = 0.009) and male sex (aOR, 1.71; 95% CI, 1.02‐2.88; P = 0.04) were associated with increased odds of long‐term cognitive delay. Waitlist duration is associated with a long‐term risk of cognitive delay. Given excellent long‐term outcomes, early LT evaluation should be considered in all children with UCDs to prevent progressive neurologic injury and optimize cognitive outcomes.